Sunniva (CSE: SNN) (OTCQX: SNNVF) recently revealed its
intention to raise C$20 million through the sale of units of the company to a
syndicate of underwriters, detailed in a company press release (http://ibn.fm/HVqPi). The terms
of the sale are an amendment of a previously announced agreement to sell 1.9
million units. An article discussing the company’s plan reads, “Sunniva
announced that the syndicate will purchase 3.8 million units priced at C$5.27
per unit, an amendment of the previously publicized agreement which said that
the syndicate was to buy 1.9 million units. Subject to the approval of the
Canadian Securities Exchange, the closing date of the deal will be October 10.
The funds realized from the sale will go toward working capital, among other
corporate expenses.”
To view the full article, visit http://ibn.fm/8RBRE
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically
integrated cannabis company operating in the world’s two largest cannabis
markets – Canada and California – where it is committed to delivering safe,
high-quality products and services at scale and creating trusted Sunniva
branded cannabis products. The company’s vision is to become one
of the lowest cost, highest quality vertically
integrated cannabis producers in the markets it serves by building
large scale purpose-built current cGMP designed greenhouses
and expansion of retail locations, offering better quality
assurance with cannabis products free from pesticides, providing
better customer access to cannabis education and sourcing better
therapeutic delivery devices. Sunniva’s management and board of
directors have a proven track record for creating significant shareholder value
both in the healthcare and biotech industries. For more information, visit the
company’s website at www.Sunniva.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
